Novosanis

8 Followers

16 SlideShares 0 Clipboards 8 Followers 2 Folgens

16 SlideShares 0 Clipboards 8 Followers 2 Folgens

Novosanis is a Belgian, award-winning, innovative developer. ISO13485 certified producer of medical devices adding value to the accuracy of diagnostics tests, drug delivery and overall patient’s comfort. Novosanis is active in the field of infectious diseases and oncology in the areas of prevention, detection and treatment. We have two device platforms in portfolio: VAX-ID™ is a patented and proven platform of injection devices suited for accurate drug delivery in the dermal layer of the skin. Colli-Pee™ is a patented and CE-marked sampling device suited for standardized and guaranteed collection of first-void urine for improved detection of infectious diseases and cancer.

innovation medical devices medical device vaccine design healthcare vaccination urine sampling intradermal vax-id colli-pee

Novosanis bio japan2013_jp

Vor 9 Jahren • 647 Aufrufe

Performance of a new first-void urine collection device

Vor 7 Jahren • 1213 Aufrufe

HPV DNA detection in urine: Effect of a first-void urine collection device and time of collection

Vor 7 Jahren • 1108 Aufrufe

The detection of hrHPV-infection of the cervix using first-void urine in women with an abnormal pap-smear

Vor 7 Jahren • 783 Aufrufe

Performance of an Automated HPV Genotyping Assay using First Void Urine Specimens

Vor 7 Jahren • 1079 Aufrufe

High Frequency ultrasound to assess skin thickness in healthy adults to determine maximum penetration depth and needle characteristics

Vor 7 Jahren • 399 Aufrufe

Microbiological evaluation of Medical grade PP in the development of a midstream collector

Vor 5 Jahren • 76 Aufrufe

Computational Modeling for the Design Optimization of a Positive Air Pressure Cleanroom

Vor 5 Jahren • 116 Aufrufe

Colli-Pee: a new device to collect first-void urina at home for molecular detection of STIs

Vor 5 Jahren • 494 Aufrufe

Research into dose sparing potential of VAX-ID

Vor 4 Jahren • 67 Aufrufe

Evaluation of injection forces of VAX-ID to maximize usability, minimize pain & cell death

Vor 4 Jahren • 98 Aufrufe

Shear Stress Test for the Determination of the Optimal Needle Diameter for Injection of Dendritic Cells

Vor 4 Jahren • 178 Aufrufe

Intradermal drug delivery: human, medical and design factors

Vor 4 Jahren • 239 Aufrufe

HF-Ultrasound to assess skin thickness and accuracy of penetration depth of VAX-ID

Vor 4 Jahren • 76 Aufrufe

Assessment of acceptability and usability of new delivery prototype device for intradermal vaccina!on in healthy subjects

Vor 4 Jahren • 1037 Aufrufe

Immunogenicity and Safety of HepatitisB Injection in the Dermis Using VAX-ID

Vor 4 Jahren • 4624 Aufrufe

Aktivität
Info

Novosanis bio japan2013_jp

Vor 9 Jahren • 647 Aufrufe

Performance of a new first-void urine collection device

Vor 7 Jahren • 1213 Aufrufe

HPV DNA detection in urine: Effect of a first-void urine collection device and time of collection

Vor 7 Jahren • 1108 Aufrufe

The detection of hrHPV-infection of the cervix using first-void urine in women with an abnormal pap-smear

Vor 7 Jahren • 783 Aufrufe

Performance of an Automated HPV Genotyping Assay using First Void Urine Specimens

Vor 7 Jahren • 1079 Aufrufe

High Frequency ultrasound to assess skin thickness in healthy adults to determine maximum penetration depth and needle characteristics

Vor 7 Jahren • 399 Aufrufe

Microbiological evaluation of Medical grade PP in the development of a midstream collector

Vor 5 Jahren • 76 Aufrufe

Computational Modeling for the Design Optimization of a Positive Air Pressure Cleanroom

Vor 5 Jahren • 116 Aufrufe

Colli-Pee: a new device to collect first-void urina at home for molecular detection of STIs

Vor 5 Jahren • 494 Aufrufe

Research into dose sparing potential of VAX-ID

Vor 4 Jahren • 67 Aufrufe

Evaluation of injection forces of VAX-ID to maximize usability, minimize pain & cell death

Vor 4 Jahren • 98 Aufrufe

Shear Stress Test for the Determination of the Optimal Needle Diameter for Injection of Dendritic Cells

Vor 4 Jahren • 178 Aufrufe

Intradermal drug delivery: human, medical and design factors

Vor 4 Jahren • 239 Aufrufe

HF-Ultrasound to assess skin thickness and accuracy of penetration depth of VAX-ID

Vor 4 Jahren • 76 Aufrufe

Assessment of acceptability and usability of new delivery prototype device for intradermal vaccina!on in healthy subjects

Vor 4 Jahren • 1037 Aufrufe

Immunogenicity and Safety of HepatitisB Injection in the Dermis Using VAX-ID

Vor 4 Jahren • 4624 Aufrufe

Novosanis is a Belgian, award-winning, innovative developer. ISO13485 certified producer of medical devices adding value to the accuracy of diagnostics tests, drug delivery and overall patient’s comfort. Novosanis is active in the field of infectious diseases and oncology in the areas of prevention, detection and treatment. We have two device platforms in portfolio: VAX-ID™ is a patented and proven platform of injection devices suited for accurate drug delivery in the dermal layer of the skin. Colli-Pee™ is a patented and CE-marked sampling device suited for standardized and guaranteed collection of first-void urine for improved detection of infectious diseases and cancer.

innovation medical devices medical device vaccine design healthcare vaccination urine sampling intradermal vax-id colli-pee